David Scott Mccaffrey, MD | |
91-2135 Fort Weaver Rd, Suite 170, Ewa Beach, HI 96706-1940 | |
(808) 676-5331 | |
(808) 671-2931 |
Full Name | David Scott Mccaffrey |
---|---|
Gender | Male |
Speciality | Preventive Medicine - Occupational Medicine |
Location | 91-2135 Fort Weaver Rd, Ewa Beach, Hawaii |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1871534321 | NPI | - | NPPES |
00E002451-2 | Other | HI | HMSA |
02217501 | Medicaid | HI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083X0100X | Preventive Medicine - Occupational Medicine | MD5473 (Hawaii) | Primary |
Mailing Address | Practice Location Address |
---|---|
David Scott Mccaffrey, MD 91-2135 Fort Weaver Rd, Suite 170, Ewa Beach, HI 96706-1940 Ph: (808) 676-5331 | David Scott Mccaffrey, MD 91-2135 Fort Weaver Rd, Suite 170, Ewa Beach, HI 96706-1940 Ph: (808) 676-5331 |
News Archive
House Judiciary Subcommittee on Immigration, Citizenship, Refugees, Border Security and International Law Chair Zoe Lofgren (D-Calif.) on Tuesday announced that she has introduced a bill (HR 5950) to establish mandatory standards for medical care for immigrants in detention centers, the New York Times reports.
This past school year was a painful one for many U.S. students, according to a new survey out today from Delta Dental. The survey finds that more than 30 percent of parents said their children between the ages of six and 12 had to miss school due to an oral health problem.
Regenicin, Inc., a development stage biotechnology company, announced today that it has completed an initial $3.25 million funding in conjunction with its acquisition of a worldwide exclusive license to know-how technology controlled by Lonza Walkersville ("Lonza Agreement").
Shionogi Inc. today announced data from a Phase IIb study that showed 0.2 mg and 0.4 mg of naldemedine demonstrated statistically significant efficacy in treating opioid-induced constipation (OIC) in patients with chronic non-cancer pain.
› Verified 2 days ago